Arkolith/Insider Trading/CCXI/Form 4

Schall Thomas J.

President and CEO, DirectorChemoCentryx, Inc. (CCXI) · full profile →Form 4 · filed Aug 8, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.5M
Net Open-Market Flow
-$6.5M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 4, 2022Option exercise(M)130K$14.28$1.9M2.5M
Aug 4, 2022Sell(S)130K$50.24$6.5M2.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 4, 2022Option exercise(M)130K——35K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-044896) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for ChemoCentryx, Inc.

Build

Ask your agent about CCXI insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001209191-22-044896"
Ask your agent
Use Arkolith to summarize insider buying and selling at ChemoCentryx, Inc.
over the last 90 days and cite the filings.